Topiramate Tablet
Product Images NDC 43063-729

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 43063-729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063729 Label (43063729)

Topiramate USP 100 mg oral tablets packaging label from PD-Rx Pharmaceuticals, Inc. The label indicates 60 tablets per bottle with NDC 43063-729-60. It includes reorder number, lot number G19D38, and expiration date 01/2021. The label also features barcode, QR code, and a warning to keep out of reach of children.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01

Chemical structure diagram of topiramate, showing its molecular arrangement including several oxygen atoms, methyl groups, and a sulfamoyl functional group.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02

A Kaplan-Meier curve showing cumulative rates for time to first seizure over 500 days comparing Topiramate 50 mg/day and 400 mg/day doses. The graph plots cumulative seizure rates on the y-axis and time in days on the x-axis, illustrating different seizure onset rates between the two dosing groups.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03

A bar graph showing change from baseline to double-blind phase in average weekly migraine periods for placebo and Topamax (topiramate) at 50 mg/day, 100 mg/day, and 200 mg/day doses across two studies (Study 10 and Study 11). The graph compares the effectiveness of different doses versus placebo with statistical significance indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.